Skip to content
Private Equity FundPuts its own capital into companiesActive · deal in last 18 monthsLAST VERIFIED Oct 2026 · 26 SOURCES

Capital Croissance

Also known as Capital Croissance SAS

Paris independent management company founded in 2012 backed by 600+ entrepreneur subscribers; runs buy-out, growth, impact VC and fund-of-funds strategies with €0.5–50M tickets.

HEADQUARTERS
Paris, France
FOUNDED
2012
AUM
—
OUTSIDE CAPITAL
Yes
TEAM LISTED
15 people

Focus

STAGES
SeedSeries ASeries BGrowthBuyout
ASSET MIX
Private equityVenture capitalFunds (as LP)Impact
GEOGRAPHY
FranceEuropeAfrica

Investment arms & vehicles

  • Buy-out and growth-capital club for French SMEs with €10–100M revenue; €285M, 300+ entrepreneur subscribers, launched 2013
  • Buy-out and growth-capital club for SMEs with €5–30M revenue; €75M, 120+ entrepreneur subscribers, launched 2021
  • €200M long-term programme (up to 15 years) backed by 14 families for French mid-caps with €50–250M revenue, launched 2019
  • Fund-of-funds and co-investment strategy in European small and lower mid-cap buyouts, active since 2008
  • Impact venture capital arm (ex-MAIF Avenir), seed to Series A in Europe
  • Impact VC fund for decentralised renewable energy in emerging markets, mainly sub-Saharan Africa; managed by Capital Croissance since 2023
  • Capital Croissance endowment fund (philanthropy)

Overview

Capital Croissance is an independent, AMF-authorised management company created in 2012 that invests equity and quasi-equity in French, European and international start-ups, SMEs and mid-caps. Its funds are subscribed by more than 600 entrepreneurs, executives, investment professionals and families, organised in business clubs: CAIRN (SMEs), Edelweiss (smaller growth companies) and K2 (mid-caps, 14 families). It also runs impact venture capital through Ternel (Europe) and Gaia Impact (emerging markets), a fund-of-funds and co-investment strategy (Bluester), and an endowment fund, Ouréa. The team numbers about fifty people.

Investment thesis

Growth and transfer transactions in profitable SMEs and mid-caps of all sectors (revenue €5–250M, tickets €1M to more than €25M) as reference shareholder; seed-to-Series A impact venture in Europe (€0.5–5M) and in emerging markets; European lower mid-market LBO exposure through fund commitments and co-investments (€3–5M).

PORTFOLIO (8)

  • EquativNOTABLE
    Media & Entertainment · since 2021
  • Bonsoirs
    Consumer & E-commerce · since 2026
  • Serapid
    Industrial & Manufacturing · since 2025
  • Cube Education
    Education · since 2025
  • Travelsoft
    Software & SaaS · since 2024
  • Stid
    Industrial & Manufacturing · since 2024
  • iDealwine
    Consumer & E-commerce · since 2021
  • Biobank
    HealthTech · since 2014

People

  • Eric Neuplanche
    Founding President (Président Fondateur) · source
  • Maxime Peronnin
    Directeur Général · source
  • Sophie Peyroutet
    Secrétaire Générale · source
  • Fabrice Fleury
    Managing Partner, CAIRN · source
  • Julie Masson
    Managing Partner, CAIRN · source
  • Julien Berger-Perrin
    Managing Partner, CAIRN · source
  • Benjamin Persyn
    Managing Partner, K2 · source
  • Arnaud Tardan
    Managing Partner, K2 · source
  • Christophe Jadot
    Managing Partner, Edelweiss · source
  • Antoine Houël
    Managing Partner, Edelweiss · source
  • Mohamed Abdesslam
    Managing Partner, Ternel · source
  • Hélène Demaegdt
    President & Founder, Gaia Impact · source
  • Victor Beulque
    Managing Partner, Gaia Impact · source
  • Anne-Sophie Kerfourn
    Managing Partner, Bluester · source
  • Arnaud Burel
    Managing Partner, Bluester · source

Links

Frequently asked questions

Capital Croissance is a private equity fund based in Paris, France, founded in 2012.

Yes. Capital Croissance invests its own capital in private companies.

Capital Croissance invests at Seed, Series A, Series B, Growth and Buyout stages in Software & SaaS, Consumer & E-commerce, Education, Industrial & Manufacturing, Media & Entertainment, HealthTech and Climate & Energy.

Capital Croissance's stated ticket size is €500K–€50M.

Key people at Capital Croissance include Eric Neuplanche (Founding President (Président Fondateur)), Maxime Peronnin (Directeur Général), Sophie Peyroutet (Secrétaire Générale) and Fabrice Fleury (Managing Partner, CAIRN).

Capital Croissance's investments include Equativ, Bonsoirs, Serapid, Cube Education, Travelsoft, Stid, iDealwine and Biobank.

The most recent publicly reported investment by Capital Croissance is Bonsoirs (Minority secondary MBO (Edelweiss Croissance I)), announced in Sep 2026.

Yes. Capital Croissance manages capital from outside investors.